🇪🇸 Spain · EU Public Tender
El objeto del contrato viene determinado por el suministro de los principios activos denominados "DURVALUMAB 500MG/ 10 ML IV" Y"ACALABRUTINIB 100MG ORAL".
🏛️ Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín · 📍 Las Palmas de Gran Canaria
194 K€
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33690000 |
| Awarded to | ASTRAZENECA FARMACEUTICA SPAIN, S.A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.